Report Detail
Global and China Imatinib Drug Market Insights, Forecast to 2026
- RnM4203494 |
- 14 September, 2020 |
- Global |
- 134 Pages |
- QYResearch |
- Pharma & Healthcare
Imatinib Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Imatinib Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Imatinib Drug market is segmented into
Tablets
Capsules
Segment by Application, the Imatinib Drug market is segmented into
Chronic myelogenous leukemia
Gastrointestinal stromal tumors
Others
Regional and Country-level Analysis
The Imatinib Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Imatinib Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Imatinib Drug Market Share Analysis
Imatinib Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Imatinib Drug business, the date to enter into the Imatinib Drug market, Imatinib Drug product introduction, recent developments, etc.
The major vendors covered:
Novartis
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Actavis Generics
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.
Sanofi S.A.
Cipla Inc.
Apotex Inc.
Mylan Pharms Inc.
1 Study Coverage
- 1.1 Imatinib Drug Product Introduction
- 1.2 Market Segments
- 1.3 Key Imatinib Drug Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Imatinib Drug Market Size Growth Rate by Type
- 1.4.2 Tablets
- 1.4.3 Capsules
- 1.5 Market by Application
- 1.5.1 Global Imatinib Drug Market Size Growth Rate by Application
- 1.5.2 Chronic myelogenous leukemia
- 1.5.3 Gastrointestinal stromal tumors
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Imatinib Drug Market Size, Estimates and Forecasts
- 2.1.1 Global Imatinib Drug Revenue 2015-2026
- 2.1.2 Global Imatinib Drug Sales 2015-2026
- 2.2 Global Imatinib Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Imatinib Drug Historical Market Size by Region (2015-2020)
- 2.3.1 Global Imatinib Drug Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.3.2 Global Imatinib Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
- 2.4 Imatinib Drug Market Estimates and Projections by Region (2021-2026)
- 2.4.1 Global Imatinib Drug Sales Forecast by Region (2021-2026)
- 2.4.2 Global Imatinib Drug Revenue Forecast by Region (2021-2026)
3 Global Imatinib Drug Competitor Landscape by Players
- 3.1 Global Top Imatinib Drug Sales by Manufacturers
- 3.1.1 Global Imatinib Drug Sales by Manufacturers (2015-2020)
- 3.1.2 Global Imatinib Drug Sales Market Share by Manufacturers (2015-2020)
- 3.2 Global Imatinib Drug Manufacturers by Revenue
- 3.2.1 Global Imatinib Drug Revenue by Manufacturers (2015-2020)
- 3.2.2 Global Imatinib Drug Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Imatinib Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Imatinib Drug Revenue in 2019
- 3.2.5 Global Imatinib Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Global Imatinib Drug Price by Manufacturers
- 3.4 Global Imatinib Drug Manufacturing Base Distribution, Product Types
- 3.4.1 Imatinib Drug Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Imatinib Drug Product Type
- 3.4.3 Date of International Manufacturers Enter into Imatinib Drug Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Imatinib Drug Market Size by Type (2015-2020)
- 4.1.1 Global Imatinib Drug Sales by Type (2015-2020)
- 4.1.2 Global Imatinib Drug Revenue by Type (2015-2020)
- 4.1.3 Imatinib Drug Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Imatinib Drug Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Imatinib Drug Sales Forecast by Type (2021-2026)
- 4.2.2 Global Imatinib Drug Revenue Forecast by Type (2021-2026)
- 4.2.3 Imatinib Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Imatinib Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Imatinib Drug Market Size by Application (2015-2020)
- 5.1.1 Global Imatinib Drug Sales by Application (2015-2020)
- 5.1.2 Global Imatinib Drug Revenue by Application (2015-2020)
- 5.1.3 Imatinib Drug Price by Application (2015-2020)
- 5.2 Imatinib Drug Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Imatinib Drug Sales Forecast by Application (2021-2026)
- 5.2.2 Global Imatinib Drug Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Imatinib Drug Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
- 6.1 China Imatinib Drug Market Size YoY Growth 2015-2026
- 6.1.1 China Imatinib Drug Sales YoY Growth 2015-2026
- 6.1.2 China Imatinib Drug Revenue YoY Growth 2015-2026
- 6.1.3 China Imatinib Drug Market Share in Global Market 2015-2026
- 6.2 China Imatinib Drug Market Size by Players (International and Local Players)
- 6.2.1 China Top Imatinib Drug Players by Sales (2015-2020)
- 6.2.2 China Top Imatinib Drug Players by Revenue (2015-2020)
- 6.3 China Imatinib Drug Historic Market Review by Type (2015-2020)
- 6.3.1 China Imatinib Drug Sales Market Share by Type (2015-2020)
- 6.3.2 China Imatinib Drug Revenue Market Share by Type (2015-2020)
- 6.3.3 China Imatinib Drug Price by Type (2015-2020)
- 6.4 China Imatinib Drug Market Estimates and Forecasts by Type (2021-2026)
- 6.4.1 China Imatinib Drug Sales Forecast by Type (2021-2026)
- 6.4.2 China Imatinib Drug Revenue Forecast by Type (2021-2026)
- 6.4.3 China Imatinib Drug Price Forecast by Type (2021-2026)
- 6.5 China Imatinib Drug Historic Market Review by Application (2015-2020)
- 6.5.1 China Imatinib Drug Sales Market Share by Application (2015-2020)
- 6.5.2 China Imatinib Drug Revenue Market Share by Application (2015-2020)
- 6.5.3 China Imatinib Drug Price by Application (2015-2020)
- 6.6 China Imatinib Drug Market Estimates and Forecasts by Application (2021-2026)
- 6.6.1 China Imatinib Drug Sales Forecast by Application (2021-2026)
- 6.6.2 China Imatinib Drug Revenue Forecast by Application (2021-2026)
- 6.6.3 China Imatinib Drug Price Forecast by Application (2021-2026)
7 North America
- 7.1 North America Imatinib Drug Market Size YoY Growth 2015-2026
- 7.2 North America Imatinib Drug Market Facts & Figures by Country
- 7.2.1 North America Imatinib Drug Sales by Country (2015-2020)
- 7.2.2 North America Imatinib Drug Revenue by Country (2015-2020)
- 7.2.3 U.S.
- 7.2.4 Canada
8 Europe
- 8.1 Europe Imatinib Drug Market Size YoY Growth 2015-2026
- 8.2 Europe Imatinib Drug Market Facts & Figures by Country
- 8.2.1 Europe Imatinib Drug Sales by Country
- 8.2.2 Europe Imatinib Drug Revenue by Country
- 8.2.3 Germany
- 8.2.4 France
- 8.2.5 U.K.
- 8.2.6 Italy
- 8.2.7 Russia
9 Asia Pacific
- 9.1 Asia Pacific Imatinib Drug Market Size YoY Growth 2015-2026
- 9.2 Asia Pacific Imatinib Drug Market Facts & Figures by Country
- 9.2.1 Asia Pacific Imatinib Drug Sales by Region (2015-2020)
- 9.2.2 Asia Pacific Imatinib Drug Revenue by Region
- 9.2.3 China
- 9.2.4 Japan
- 9.2.5 South Korea
- 9.2.6 India
- 9.2.7 Australia
- 9.2.8 Taiwan
- 9.2.9 Indonesia
- 9.2.10 Thailand
- 9.2.11 Malaysia
- 9.2.12 Philippines
- 9.2.13 Vietnam
10 Latin America
- 10.1 Latin America Imatinib Drug Market Size YoY Growth 2015-2026
- 10.2 Latin America Imatinib Drug Market Facts & Figures by Country
- 10.2.1 Latin America Imatinib Drug Sales by Country
- 10.2.2 Latin America Imatinib Drug Revenue by Country
- 10.2.3 Mexico
- 10.2.4 Brazil
- 10.2.5 Argentina
11 Middle East and Africa
- 11.1 Middle East and Africa Imatinib Drug Market Size YoY Growth 2015-2026
- 11.2 Middle East and Africa Imatinib Drug Market Facts & Figures by Country
- 11.2.1 Middle East and Africa Imatinib Drug Sales by Country
- 11.2.2 Middle East and Africa Imatinib Drug Revenue by Country
- 11.2.3 Turkey
- 11.2.4 Saudi Arabia
- 11.2.5 U.A.E
12 Company Profiles
- 12.1 Novartis
- 12.1.1 Novartis Corporation Information
- 12.1.2 Novartis Description and Business Overview
- 12.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 12.1.4 Novartis Imatinib Drug Products Offered
- 12.1.5 Novartis Recent Development
- 12.2 Glenmark Pharmaceuticals Ltd.
- 12.2.1 Glenmark Pharmaceuticals Ltd. Corporation Information
- 12.2.2 Glenmark Pharmaceuticals Ltd. Description and Business Overview
- 12.2.3 Glenmark Pharmaceuticals Ltd. Sales, Revenue and Gross Margin (2015-2020)
- 12.2.4 Glenmark Pharmaceuticals Ltd. Imatinib Drug Products Offered
- 12.2.5 Glenmark Pharmaceuticals Ltd. Recent Development
- 12.3 Sun Pharmaceuticals
- 12.3.1 Sun Pharmaceuticals Corporation Information
- 12.3.2 Sun Pharmaceuticals Description and Business Overview
- 12.3.3 Sun Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 12.3.4 Sun Pharmaceuticals Imatinib Drug Products Offered
- 12.3.5 Sun Pharmaceuticals Recent Development
- 12.4 Actavis Generics
- 12.4.1 Actavis Generics Corporation Information
- 12.4.2 Actavis Generics Description and Business Overview
- 12.4.3 Actavis Generics Sales, Revenue and Gross Margin (2015-2020)
- 12.4.4 Actavis Generics Imatinib Drug Products Offered
- 12.4.5 Actavis Generics Recent Development
- 12.5 Dr. Reddy's Laboratories
- 12.5.1 Dr. Reddy's Laboratories Corporation Information
- 12.5.2 Dr. Reddy's Laboratories Description and Business Overview
- 12.5.3 Dr. Reddy's Laboratories Sales, Revenue and Gross Margin (2015-2020)
- 12.5.4 Dr. Reddy's Laboratories Imatinib Drug Products Offered
- 12.5.5 Dr. Reddy's Laboratories Recent Development
- 12.6 Teva Pharmaceutical Industries Ltd.
- 12.6.1 Teva Pharmaceutical Industries Ltd. Corporation Information
- 12.6.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
- 12.6.3 Teva Pharmaceutical Industries Ltd. Sales, Revenue and Gross Margin (2015-2020)
- 12.6.4 Teva Pharmaceutical Industries Ltd. Imatinib Drug Products Offered
- 12.6.5 Teva Pharmaceutical Industries Ltd. Recent Development
- 12.7 Sanofi S.A.
- 12.7.1 Sanofi S.A. Corporation Information
- 12.7.2 Sanofi S.A. Description and Business Overview
- 12.7.3 Sanofi S.A. Sales, Revenue and Gross Margin (2015-2020)
- 12.7.4 Sanofi S.A. Imatinib Drug Products Offered
- 12.7.5 Sanofi S.A. Recent Development
- 12.8 Cipla Inc.
- 12.8.1 Cipla Inc. Corporation Information
- 12.8.2 Cipla Inc. Description and Business Overview
- 12.8.3 Cipla Inc. Sales, Revenue and Gross Margin (2015-2020)
- 12.8.4 Cipla Inc. Imatinib Drug Products Offered
- 12.8.5 Cipla Inc. Recent Development
- 12.9 Apotex Inc.
- 12.9.1 Apotex Inc. Corporation Information
- 12.9.2 Apotex Inc. Description and Business Overview
- 12.9.3 Apotex Inc. Sales, Revenue and Gross Margin (2015-2020)
- 12.9.4 Apotex Inc. Imatinib Drug Products Offered
- 12.9.5 Apotex Inc. Recent Development
- 12.10 Mylan Pharms Inc.
- 12.10.1 Mylan Pharms Inc. Corporation Information
- 12.10.2 Mylan Pharms Inc. Description and Business Overview
- 12.10.3 Mylan Pharms Inc. Sales, Revenue and Gross Margin (2015-2020)
- 12.10.4 Mylan Pharms Inc. Imatinib Drug Products Offered
- 12.10.5 Mylan Pharms Inc. Recent Development
- 12.11 Novartis
- 12.11.1 Novartis Corporation Information
- 12.11.2 Novartis Description and Business Overview
- 12.11.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 12.11.4 Novartis Imatinib Drug Products Offered
- 12.11.5 Novartis Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Imatinib Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Imatinib Drug Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Imatinib Drug. Industry analysis & Market Report on Imatinib Drug is a syndicated market report, published as Global and China Imatinib Drug Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Imatinib Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
